Risk Measurement of Perinatal and Neonatal Morbidity Characteristics and Applicability of GAIA Case Definitions: Results and Lessons Learnt of a Hospital-Based Prospective Cohort Study in the Valencia Region (2019-2020)

Autor: Carmona A, Latorre Tejerina M, Martínez Sebastián A, Dobreva D, Jurca CP, Huerta Barberá S, Bernat Montoya V, Aristoy Zabaleta M, Pineda Caplliure A, Mansilla Roig B, Navío Anaya M, Tosca-Segura R, Tortajada-Girbés M, Díez-Domingo J, Orrico-Sánchez A

Publikováno v: INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
r-FISABIO. Repositorio Institucional de Producción Científica
instname

Post-marketing safety surveillance of new vaccines aimed to be administered during pregnancy is crucial to orchestrate efficient adverse events evaluation. This is of special relevance in the current landscape of new vaccines being introduced in the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::7f3380ff89f720e279494a58666363df
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13726